BIOMIN, a.s.

Active
IČO 00681725joint-stock company (a.s.)Founded 1990Cífer

Key figures

6 992 784 €+33,2%
Revenue 2025
+16,5%
Average annual growth 2020–2025
02 m4 m6 m8 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 41 183 € (5 % of distributable profit).

In addition, equity decreased by 157 658 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.

History
dividends other decrease in equity
202541 183 €+157 658 € other
202433 800 €+88 200 € other
2023 ~15 037 €
2022 ~15 003 €
2021 ~9 950 €

Summary: BIOMIN, a.s.

What kind of company is it?

BIOMIN, a.s. (IČO 00681725) is a joint-stock company (a.s.). The company was incorporated in 1990 and has existed for 36 years. Registered office according to the register: Cífer. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 25–49 employees.

Who runs the company and who owns it?

The statutory body has 3 members. The supervisory board has 3 members. The registered capital is 585 000 €.

How is the company doing financially?

Revenue for 2025 was 6 992 784 €, up 33,2 % on the previous year (5 248 584 €). From 2020 to 2025, revenue grew by an average of 16,5 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 807 260 € (11,5 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 1 010 460 €. At the end of 2025 the company had total assets of 5 566 815 € and equity of 3 628 381 € (equity ratio 65,2 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 22. 11. 2026. The LEI code (097900CAKA0000143244) comes from the GLEIF database. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)4 622 8033 636 8074 331 1425 248 5846 992 784
Profit for the reporting year327 889226 195114 087173 422807 260
Retained earnings of previous periods130 382410 480599 018679 305811 544
Total assets5 229 7825 500 2125 078 6165 020 7235 566 815
Total liabilities1 920 6032 008 4921 577 0991 406 1441 428 975
Total equity2 658 2982 869 4902 968 5403 019 9623 628 381
Calculated dividends9 95015 00315 03733 80041 183

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
board of directors · supervisory boardboard of directorsboard of directorssupervisory boardsupervisory boardBIOMIN, a.s.BIOMIN, a.s.JGIng. Ján GunišIng. Ján GunišJVMVDr. Juraj VozárMVDr. Juraj VozárTVTereza VozárováTereza VozárováMPIng. Martin PrigancIng. Martin PrigancMKIng. Monika KošuthováIng. Monika Košuthová
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements12

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 2120)
BIOMIN, a.s. (IČO 00681725) – revenue 7M €, 25–49 employees